Skip to main content
FDA Shortage Check

Is Ravicti (Glycerol Phenylbutyrate Oral Liquid) being discontinued?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

DISCONTINUATION NOTICE

Ravicti: being discontinued (FDA, Oct 24)

Oral solutions & syrups
A generic oral solution, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
DRUG
Ravicti
FDA LISTING
FORM
oral solution
STATUS
Discontinuation
FIRST POSTED
Sep 1, 2026
LAST FDA UPDATE
Sep 1, 2026
AS OF
Oct 24, 2026
SOURCE

1 discontinuation notice below, in FDA's words. A discontinuation “does not necessarily create a shortage” (FDA).

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Glycerol Phenylbutyrate Oral Liquid. 2 presentations from 1 maker.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Discontinuation notices

A discontinuation “does not necessarily create a shortage” (FDA).

  • Amgen Inc. told FDA it will discontinue RAVICTI (posted ).

    “Discontinuation in the manufacturing of the drug product”

    FDA listing: Glycerol Phenylbutyrate Oral Liquid

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Ravicti being discontinued?
As of Oct 24, 2026, FDA lists discontinuation notices for Glycerol Phenylbutyrate Oral Liquid, not a shortage. A discontinuation “does not necessarily create a shortage” (FDA).
When will the Ravicti shortage end?
FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Ravicti?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.